These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21652770)

  • 1. Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression.
    Shiota M; Takeuchi A; Song Y; Yokomizo A; Kashiwagi E; Uchiumi T; Kuroiwa K; Tatsugami K; Fujimoto N; Oda Y; Naito S
    Endocr Relat Cancer; 2011 Aug; 18(4):505-17. PubMed ID: 21652770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cells.
    Kita K; Shiota M; Tanaka M; Otsuka A; Matsumoto M; Kato M; Tamada S; Iwao H; Miura K; Nakatani T; Tomita S
    Cancer Sci; 2017 Sep; 108(9):1820-1827. PubMed ID: 28691182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells.
    Recouvreux MV; Wu JB; Gao AC; Zonis S; Chesnokova V; Bhowmick N; Chung LW; Melmed S
    Endocrinology; 2017 Jul; 158(7):2255-2268. PubMed ID: 28444169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage.
    Li L; Xie H; Liang L; Gao Y; Zhang D; Fang L; Lee SO; Luo J; Chen X; Wang X; Chang LS; Yeh S; Wang Y; He D; Chang C
    Carcinogenesis; 2013 Feb; 34(2):257-67. PubMed ID: 23104178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological inhibition of androgen receptor expression induces cell death in prostate cancer cells.
    Song IS; Jeong YJ; Kim J; Seo KH; Baek NI; Kim Y; Kim CS; Jang SW
    Cell Mol Life Sci; 2020 Nov; 77(22):4663-4673. PubMed ID: 31894360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor variants occur frequently in castration resistant prostate cancer metastases.
    Zhang X; Morrissey C; Sun S; Ketchandji M; Nelson PS; True LD; Vakar-Lopez F; Vessella RL; Plymate SR
    PLoS One; 2011; 6(11):e27970. PubMed ID: 22114732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor transcriptional activity is required for heregulin-1β-mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase.
    Jathal MK; Siddiqui S; Vasilatis DM; Durbin Johnson BP; Drake C; Mooso BA; D'Abronzo LS; Batra N; Mudryj M; Ghosh PM
    J Biol Chem; 2023 Aug; 299(8):104973. PubMed ID: 37380074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen-repressed lncRNA LINC01126 drives castration-resistant prostate cancer by regulating the switch between O-GlcNAcylation and phosphorylation of androgen receptor.
    Cai Y; Chen M; Gong Y; Tang G; Shu Z; Chen J; Zhou H; He Y; Long Z; Gan Y
    Clin Transl Med; 2024 Jan; 14(1):e1531. PubMed ID: 38214432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JMJD2A promotes the development of castration-resistant prostate cancer by activating androgen receptor enhancer and inhibiting the cGAS-STING pathway.
    Cai X; Yu X; Tang T; Xu Y; Wu T
    Mol Carcinog; 2024 Sep; 63(9):1682-1696. PubMed ID: 38818897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.
    Sun S; Sprenger CC; Vessella RL; Haugk K; Soriano K; Mostaghel EA; Page ST; Coleman IM; Nguyen HM; Sun H; Nelson PS; Plymate SR
    J Clin Invest; 2010 Aug; 120(8):2715-30. PubMed ID: 20644256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP11 promotes prostate cancer progression by up-regulating AR and c-Myc activity.
    Pornour M; Jeon HY; Ryu H; Khadka S; Xu R; Chen H; Hussain A; Lam HM; Zhuang Z; Oo HZ; Gleave M; Dong X; Wang Q; Barbieri C; Qi J
    Proc Natl Acad Sci U S A; 2024 Jul; 121(31):e2403331121. PubMed ID: 39052835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYB interacts with androgen receptor, sustains its ligand-independent activation and promotes castration resistance in prostate cancer.
    Srivastava SK; Khan MA; Anand S; Zubair H; Deshmukh SK; Patel GK; Singh S; Andrews J; Wang B; Carter JE; Singh AP
    Br J Cancer; 2022 May; 126(8):1205-1214. PubMed ID: 34837075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USP54 is a potential therapeutic target in castration-resistant prostate cancer.
    Zhou C; Zhang X; Ma H; Zhou Y; Meng Y; Chen C; Shi G; Yu W; Zhang J
    BMC Urol; 2024 Feb; 24(1):32. PubMed ID: 38321455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer.
    Munkley J; Oltean S; Vodák D; Wilson BT; Livermore KE; Zhou Y; Star E; Floros VI; Johannessen B; Knight B; McCullagh P; McGrath J; Crundwell M; Skotheim RI; Robson CN; Leung HY; Harries LW; Rajan P; Mills IG; Elliott DJ
    Oncotarget; 2015 Oct; 6(33):34358-74. PubMed ID: 26452038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of histone lysine demethylase KDM4B blocks the growth of castration-resistant prostate cancer.
    Duan L; Chen YA; Liang Y; Chen Z; Lu J; Fang Y; Cao J; Lu J; Zhao H; Pong RC; Hernandez E; Kapur P; Tran TAT; Smith T; Martinez ED; Ahn JM; Hsieh JT; Luo JH; Liu ZP
    Biomed Pharmacother; 2023 Feb; 158():114077. PubMed ID: 36495660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis.
    Massie CE; Lynch A; Ramos-Montoya A; Boren J; Stark R; Fazli L; Warren A; Scott H; Madhu B; Sharma N; Bon H; Zecchini V; Smith DM; Denicola GM; Mathews N; Osborne M; Hadfield J; Macarthur S; Adryan B; Lyons SK; Brindle KM; Griffiths J; Gleave ME; Rennie PS; Neal DE; Mills IG
    EMBO J; 2011 May; 30(13):2719-33. PubMed ID: 21602788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer.
    Reyes EE; VanderWeele DJ; Isikbay M; Duggan R; Campanile A; Stadler WM; Vander Griend DJ; Szmulewitz RZ
    J Transl Med; 2014 Nov; 12():313. PubMed ID: 25424879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.
    Qi J; Tripathi M; Mishra R; Sahgal N; Fazli L; Ettinger S; Placzek WJ; Claps G; Chung LW; Bowtell D; Gleave M; Bhowmick N; Ronai ZA
    Cancer Cell; 2013 Mar; 23(3):332-46. PubMed ID: 23518348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer.
    Shaw GL; Whitaker H; Corcoran M; Dunning MJ; Luxton H; Kay J; Massie CE; Miller JL; Lamb AD; Ross-Adams H; Russell R; Nelson AW; Eldridge MD; Lynch AG; Ramos-Montoya A; Mills IG; Taylor AE; Arlt W; Shah N; Warren AY; Neal DE
    Eur Urol; 2016 Aug; 70(2):214-8. PubMed ID: 26572708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors.
    Takayama KI; Fujimura T; Suzuki Y; Inoue S
    Commun Biol; 2020 Jul; 3(1):393. PubMed ID: 32704143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.